David R. Bristol

N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2 H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: II. In Vivo Characterization in Rat Models of Inflammatory and Neuropathic Pain

James D. Pomonis, James Harrison, Lilly Mark et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 261 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Treatment of Dry Eye Syndrome with Orally Administered CF101

Isaac Avni, Hanna J. Garzozi, Irina S. Barequet et al. · Ophthalmology · 2010 · 83 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +11

Changes in fecal flora and comparative multiple-dose pharmacokinetics of ceftibuten, cefpodoxime proxetil and amoxycillin/clavulanate

Jörg Hamacher, Jörg Luepke, Bruce E. Reidenberg et al. · Clinical Microbiology and Infection · 1999 · 11 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +9